Author: van Veen A. Weller F.R. Wierenga E.A. Jansen H.M. Jonkers R.E.
Publisher: Elsevier
ISSN: 1094-5539
Source: Pulmonary Pharmacology & Therapeutics, Vol.16, Iss.3, 2003-06, pp. : 153-161
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Which long-acting 2-agonist is best? Formoterol vs salmeterol
Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. :
By Grembiale R.D. Pelaia G. Naty S. Vatrella A. Tranfa C.M.E. Marsico S.A.
Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 5, 2002-10 ,pp. :
By Verini M. Verrotti A. Greco R. Chiarelli F.
Clinical Drug Investigation, Vol. 16, Iss. 1, 1998-07 ,pp. :
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. :